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EmbryogenesisThe small GTP-binding protein Rac1, a member of the Rho family of small GTPases, has been implicated in
regulation of many cellular processes including adhesion, migration and cytokinesis. These functions have
largely been attributed to its ability to reorganize cytoskeleton. While the function of Rac1 is relatively well
known in vitro, its role in vivo has been poorly understood. It has previously been shown that in neural crest
cells (NCCs) Rac1 is required in a stage-speciﬁc manner to acquire responsiveness to mitogenic EGF signals.
Here we demonstrate that mouse embryos lacking Rac1 in neural crest cells (Rac1/Wnt1-Cre) showed
abnormal craniofacial development including regional ectodermal detachment associated with mesench-
ymal acellularity culminating in cleft face at E12. Rac1/Wnt1-Cre mutants also displayed inappropriate
remodelling of pharyngeal arch arteries and defective outﬂow tract septation resulting in the formation of a
common arterial trunk (‘persistent truncus arteriosus’ or PTA). The mesenchyme around the aortic sac also
developed acellular regions, and the distal aortic sac became grossly dysmorphic, forming a pair of bilateral,
highly dilated arterial structures connecting to the dorsal aortas. Smooth muscle cells lacking Rac1 failed to
differentiate appropriately, and subpopulations of post-migratory NCCs demonstrated aberrant cell death
and attenuated proliferation. These novel data demonstrate that while Rac1 is not required for normal NCC
migration in vivo, it plays a critical cell-autonomous role in post-migratory NCCs during craniofacial and
cardiac development by regulating the integrity of the craniofacial and pharyngeal mesenchyme.ll rights reserved.© 2010 Elsevier Inc. All rights reserved.Introduction
Craniofacial and cardiac malformations are among the most
common birth defects in humans. Their pathogenesis often involves
cranial neural crest cells (NCC), a migratory, pluripotent population of
cells originating from dorsal neural tube from midbrain to third
somite levels (Le Douarin et al., 2004; LeDouarin, 1982). In the mouse,
this migration starts as the neural plate folds around the 4–5 somite
pairs stage, embryonic day 7.5 (E7.5)(Gilbert, 2006; Nichols, 1986).
The most rostral cranial NCCs migrate to the frontal nasal process and
the maxillary processes of the ﬁrst pharyngeal arch, where they form
most of the skull, and the mesenchymal structures of the developing
maxilla, respectively. Cranial NCCs from the hindbrain level populate
the mandibular process of the ﬁrst pharyngeal arch, and the second
and third pharyngeal arches, where they form the mesenchymal
derivatives of the mandible, neck and pharyngeal organs (Chai et al.,
2000). The most caudal cranial NCCs (from rhombomeric level 5 to
somatic level 3) are known as the cardiac neural crest (Creazzo et al.,
1998). These cells contribute to the smooth muscle cell layer coveringthe ascending aorta and derivatives of the third, fourth and sixth
aortic arch arteries (PAA3, 4 and 6). A subpopulation of cardiac NCCs
forms the aortico-pulmonary (AP) septum, and migrates into the
outﬂow tract (OFT) cushions of the heart, playing an important role in
the formation of separate aortic and pulmonary valves and trunks
(Jiang et al., 2000).
Crucial to the onset of NCC migration are changes in cell shape and
formation and maintenance of subcellular structures such as ﬁlopodia
and lamellipodia that facilitate cell migration (Ridley et al., 2003).
Many aspects of these are dependent on the complex functions of
small Rho-related GTPases that act as molecular switches and regulate
rapid assembly and destruction of actin ﬁlaments (Kaibuchi et al.,
1999). The Rho small GTPase protein family consists of Rho, Cdc42 and
Rac subfamilies (Ridley, 2006). Each member has been suggested to
have its own cell-type-speciﬁc functions. For instance, in Swiss 3T3
ﬁbroblasts, RhoA, Cdc42 and Rac1 regulate the formation of actin
stress ﬁbers, ﬁlopodia and lamellipodia, respectively (Ridley and Hall,
1992; Ridley et al., 1992). The Rac subfamily is composed of three
members: Rac1, Rac2 and Rac3 (Haataja et al., 1997). Rac1 is
expressed ubiquitously. Rac2 expression is limited to hematopoietic
tissues and Rac3 is predominanty expressed in the central nervous
system. Other important functions of Rho-related GTPases include
regulation of cell proliferation, migration, apoptosis and gene
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et al., 2003).
Mouse embryos deﬁcient in Rac1 fail to form appropriate germ cell
layers and die at gastrulation (Sugihara et al., 1998). Rac1-deﬁcient
neutrophils display defects in inﬂammatory recruitment, migration to
chemotactic stimuli, and chemo-attractant-mediated actin assembly
(Glogauer et al., 2003). Similarly, deletion of Rac1 in endothelial cells
causes defects in their migration and in angiogenesis (Tan et al.,
2008). It has recently been reported that, rather than being necessary
for migration, Rac1 is required in NCCs in a stage-speciﬁc manner to
acquire responsiveness to mitogenic EGF signals (Fuchs et al., 2009).
Here we extend and complement the ﬁndings of this study by
examining the effects of Rac1 deﬁciency in NCCs on craniofacial and
cardiovascular development. Our results show that Rac1 in cranial
NCCs is required for normal face and cardiovascular morphogenesis.
Lack of Rac1 in cranial NCCs in vivo leads to localized defects in
integrity of adhesion between epithelia and underlying NC-derived
mesenchyme, severe mid-face clefting, regional apoptosis of post-
migratory pharyngeal NCCs, defective differentiation of muscle cells
adjacent to the aortic sac and aortic arch arteries, and abnormal
morphogenesis of the cardiac outﬂow tract and great arteries.
Materials and methods
Mouse breeding, genotyping and generation of embryos for analysis
Wnt1-Cre mice were obtained from the Jackson Laboratories and
generation of Rac1FXFX and R26R mice has been described earlier
(Glogauer et al., 2003; Soriano, 1999). Rac1Fx/Fx or Rac1Fx/Fx/R26R+/
+ female mice were crossed with Rac1Fx/+/Wnt1-Cre male mice to
obtain timed pregnancies. As the dark period was 2 am–2 pm, the
presence of vaginal plug was designated as embryonic day 0 (E0).
DNA for genotyping was prepared from yolk sac or tail lysate using
DirectPCR Lysis Reagents (Viagen Biotech). Rac1fx/fx and Wnt1-Cre
mice were genotyped by PCR as described in the text of supplemental
Fig. 1 and in (Glogauer et al., 2003). To prolong the life of mutant
genotype embryos, some females were treated with 200 µg/ml
isoproterenol delivered in drinking water (Morikawa and Cserjesi,
2008). Pregnant females were euthanized with CO2 according to
National and Institutional guidelines. Embryos were genotyped using
yolk sac DNA.
Histology, immunochemistry, cell death and proliferation assays
Embryos were collected at stages of interest, rinsed in PBS, ﬁxed
overnight in 4% buffered paraformaldehyde at 4 °C, washed, dehy-
drated and embedded in Leica Histowax. 7 μm sections were stained
with haematoxylin and eosin using a standard protocol. Smooth
muscle α-actin antibody (M 0851, 1:50, DAKO) binding was detect-
ed using biotin–streptavidin HRP kit (Zymed) and mounted in Immu-
mount (Thermoscientiﬁc), or Alexaﬂuor-594 goat anti-mouse
(Invitrogen) and mounted as below. Anti-striated muscle myosin
antibody (MF20, 1:500 after heat retrieval, DSHB) binding was
detected using Alexaﬂuor goat anti-mouse (Invitrogen) and mounted
as below. Apoptotic cells were detected using Dead End Fluorometric
TUNEL system (Promega) following manufacturer's instructions. Cell
proliferation was assessed using Cell proliferation labelling reagent
(RPN201, 200 μl ip injection), and then anti BrdU antibody (RPN202,
GE Healthcare/Amersham) on tissue sections following antigen
retrieval, detected using Alexaﬂuor-488 goat anti-mouse antibodies
(Invitrogen) and mounted in Vectashield with propidium iodide or
with DAPI nuclear stain (Vector Labs Inc). Anti phospho-histone H3
antibody (after antigen retrieval, 9701, 1:50, Cell Signaling) binding
was detected using Alexaﬂuor antibodies and mounted as above.
Fluorescent images were viewed on an Olympus BX51 withﬂuorescence attachments and photographed using an Olympus
DP71 camera and DP controller and manager software.
R26R fate determination assay and cell shape analysis
Embryos at stages of interest, cultured cells or tissues were rinsed
several times in DPBS, ﬁxed in 4% buffered paraformaldehyde or 0.25%
buffered glutaraldehyde for 5–15 min at 4 °C, washed and stained
using a standard β-galactosidase staining protocol including X-gal
(Soriano, 1999), washed in detergent rinse or PBS and ﬁxed. Whole-
mounts and cultures were examined using a Leica MZ95 dissecting
microscope and photographed as above). Some embryos were
processed for wax embedding and sectioned at 7 μm and mounted
in Immu-mount (Thermoscientiﬁc), then examined on Olympus BX51
microscope and photographed as described previously. For cell shape
studies, 80 cells were selected randomly from four separate high
resolution images per outﬂow tract and analyzed using DP Manager
and Excel software. Each analysis was performed with at least three
independent samples.
Whole-mount in situ hybridization and immunohistochemistry
Whole-mount immunohistochemistry was performed as de-
scribed (Hogan et al., 1994) using anti-neuroﬁlament 2H3 (DSHB)
and anti-Pecam1 (CD31, 550274, BD-Pharmingen) antibodies. Bind-
ing was detected using biotin–streptavidin HRP (Zymed) and
SigmaFastTM DAB with Metal Enhancer Tablet Set.
For whole-mount RNA in situ hybridization, embryos were
collected on ice, ﬁxed in 4% buffered formaldehyde for 12 h and
dehydrated with ethanol. Antisense RNA probes were synthesized
with NTP DIG RNA labelling mix (Roche Applied Science) following
manufacturer's instructions. Probe templates for Krox20, Cad6, EphA4
and Sox10 were obtained from R. Maxson (Keck School of Medicine,
USC (Ishii et al., 2005)) and for Pitx2 and Axin2 from S. Bellusci
(Childrens Hospital Los Angeles (De Langhe et al., 2008)). Bmp2,
Bmp4,Msx1 andMsx2 templates, and ISH protocol, were as previously
described (Kaartinen et al., 2004). Each analysis was performed with
at least three independent samples.
Transmission electron microscopy
Embryos at E11 were rapidly recovered, washed with DPBS on ice
and processed according to protocols used by the Microscope Image
Analysis Laboratory (University of Michigan Medical School). Brieﬂy,
tissues were ﬁxed in 4% paraformaldehyde (EM grade), 2.5%
glutaraldehyde in cacodylate buffer at 4 °C overnight. After several
washes to remove the ﬁxative, tissues were further dissected to
isolate regions for sectioning. These were reﬁxed as above for several
days, post-ﬁxed in osmium tetroxide, en bloc stained in uranyl acetate
and dehydrated to propylene oxide. They were then inﬁltrated and
embedded in Epon resin. Semi-thin sectioning was performed to
identify regions of interest and ultra thin sections collected, post-
stained with uranyl acetate and lead citrate and examined on a
Philips CM100 transmission electron microscope operated at 60KV.
High resolution images were recorded digitally using a Hamamatsu
ORCA-HR camera system, operated using AMT software (Advanced
Microscopy Techniques, Danvers, MA).
Isolation of neural crest cells from the 1st pharyngeal arch
Maxillary and mandibular processes were dissected from E10
embryos in PBS using microscissors. The isolated tissues were
dissociated using trypsin (0.25%), and single cell suspensions plated
on ﬁbronectin, laminin or collagen-coated dishes (all from BD
Biosciences), cultured at 37 °C, 8% CO2 for 3–4 days, and stained for
β-galactosidase activity as described above (R26R fate determination
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with 4% buffered paraformaldehyde. Antibodies speciﬁc for FAK (05-
537, Upstate) and β-galactosidase (ab616 abcam), and FITC-phalloi-
din (77415, Sigma), were detected, visualized and recorded as
described previously. In some experiments, cells were serum-starved
for 2 h and stimulated with 100 ng/ml each of epidermal growth
factor (human recombinant EGF, Sigma) and basic ﬁbroblast growth
factor (human bFGF, Sigma) for 1 h. Each analysis was performedwith
at least three independent samples.
2D Neural tube culture
E9 embryos were collected in HBSS on ice. Isolation of individual
neural tubes was achieved by removing the head and tail regions and
treating the trunk segment with 0.15% dispase for 10–15 min whilst
triturating with a pipette to loosen and displace all remaining non-
neural tube cells. They were then washed in HBSS/10%FBS to inhibit
further dispase activity. Isolated tubes were placed on collagen-coated
tissue culture dishes and incubated in DMEM/F-12 (Invitrogen)
containing 10%FBS (Invitrogen), 1× Pen Strep (Sigma) and 1× ITS
(Invitrogen) at 37 °C 8% CO2 for 48 h. They were then washed, ﬁxed
and stained for β-galactosidase activity (see R26R fate determination
assay above). Five independent samples were used for this assay.
Immunoblotting
First pharyngeal arch tissues were harvested, snap-frozen and
stored at −80 °C until genotype known. Selected arches (pools of
three controls and mutants) were then lysed in 2× Laemmli lysis
buffer (Harlow and Lane, 1988). Proteins were resolved on NuPAGE
BisTris SDS-PAGE gels (Invitrogen) using the X-Cell SureLockMini-Cell
electrophoresis system (Invitrogen) according to the manufacturer's
instructions. After electrotransfer to PVDF membrane, the ﬁlters were
blocked (5% milk in TBST) and probed with speciﬁc monoclonal anti
Rac1 (ARC03; 1:1000, Cytoskeleton Inc) and anti β-Actin (A1978;
1:2000, Sigma) antibodies, followed by HRP-conjugated anti-mouse
antibodies. Immunoblots were visualized using ECL reagents (Immo-
bilon, Amersham) and BioSpectrum AC imaging system (UVP).
Results
We deleted Rac1 in mouse in neural crest cells (NCC) by crossing
females homozygous for the ﬂoxed Rac1 allele (Rac1Flox/Flox) with
males heterozygous both for the ﬂoxed Rac1 allele and Wnt1-Cre
transgene (Rac1Flox/+/Wnt1-Cre+/−) (Danielian et al., 1998; Glogauer et
al., 2003). The resulting Rac1Flox/Flox/Wnt1-Cre+/− mice (herein desig-
nated Rac1/Wnt1-Cre, or ‘mutant’) had exon 1 of the Rac1 gene deleted.
Rac1 protein was absent in the NC lineage by at least as early as
embryonic day 10 (E10)(Suppl. Fig 1). Littermateswith the other genetic
combinations generatedwere used as controls. Embryos from crosses to
generate Rac1/Wnt1-Cre mice were recovered at different embryonic
stages and genotyped. The mutant genotype (Rac1/Wnt1-Cre) was not
lethal until E12, when occasional live mutants were very edematous,
unlike control littermates. Treatment of pregnant mothers with
isoproterenol enabled theoccasional survival ofRac1/Wnt1-Creembryos
toE13, suggesting anoradrenergic deﬁciencymight play somerole in the
early lethality.
Rac1/Wnt1-Cre mutants develop severe craniofacial defects
At E10, mutant embryos appeared superﬁcially indistinguishable
from controls. This was the case even for the pharyngeal arches,
largely populated by migrating NCCs (Figs. 1A–B). However, even at
this early stage, localized regions of detachment of the epithelial
surface ectoderm from its underlying mesenchyme were detectable
on the lateral aspects of the ﬁrst pharyngeal arches in some mutantembryos (Fig. 1D). At E11, heads of mutants were noticeably wider
(Fig. 1H and Suppl. Fig. 2), and the medial nasal processes further
apart than in controls (Fig. 1H)where they were in direct contact with
one another (Fig. 1G). By this stage, very prominent and blister-like
epithelial detachment on the lateral parts of the mandibular arches
was consistently present (Fig. 1F). Histological analysis conﬁrmed
this, but also that pharyngeal arches otherwise contained plentiful
relatively normal-appearing mesenchymal cells. In addition, the
vascular beds of the ﬁrst pharyngeal arch in control and mutants
appeared indistinguishable at E10 (Figs. 4F, H).
Epithelial detachment was also obvious in the facial midline at E11
(Figs. 1F and 2D). At E12, all survivingmutant embryos showed severe
mid-facial clefting (Fig. 1J), likely the result of failure of left and right
medial nasal processes to fuse, along with a more extensive region of
epithelial detachment in the midline. The arch blister phenotype,
prominent on the mandibular arch at E11, was now consistently seen
on the maxillary processes too (Fig. 1J). At E13, in addition to the cleft
face, the mid-face blisters were even more extensive and also blood-
ﬁlled (Fig. 1N and Suppl. Fig. 2D). The mutant heads remained much
wider than those of controls, the ventricular lumen in particular being
larger. In contrast, the amount of craniofacial mesenchyme was
considerably less in mutants than in controls; in particular, the
posterior palatal shelves were rudimentary when compared to those
of control littermates (Figs. 1O–R).
The R26R fate determination assay (Soriano, 1999) conﬁrmed that
even by E10 the distribution of NC-derived cells in Rac1/Wnt1-Cre
mutants was detectably different in developing facial processes when
viewed en face from that of corresponding control littermates
(Figs. 2A–B). While differences in gross head width at this early
time point were not so evident, the darkly staining accumulated NC-
derived cells in controls formed a narrower V-shaped pattern,
reﬂecting more medially located boundaries on each side, while the
corresponding cell populations in the mutants were further apart. At
E10 there were few if any cells in the midline even in controls (data
not shown) but by E11, the lack of cellularity in the midline region
associated with epithelial blistering was obvious (Figs. 2C–D). In
addition, at a more rostral horizontal level, the NC-derived mesen-
chymal cells remained predominantly in amore lateral position, while
the midline region was consistently hypo- or acellular (Figs. 2E–F).
Molecular mechanisms underlying many aspects of craniofacial
morphogenesis have been established, so to examine if Rac1 is
upstream of the expression of known key players in NC-derived
mesenchyme or adjacent ectodermal structures, whole-mount RNA
ISH was performed to examine the distribution of Bmp2 and Bmp4
(encoding members of the Tgf-β superfamily), their downstream
targets, homeobox genesMsx1 andMsx2, in NC-derived mesenchyme
and Pitx2 and Fgf8 in the interacting craniofacial ectoderm (Liu et al.,
2003, 2005; Meyers et al., 1998) at E10 and E11. We could not detect
any noticeable differences in expression of any of these genes
between Rac1/Wnt1-Cre mutants and their control littermates
(Suppl. Fig. 3, and data not shown). A recent study demonstrated
that Rac1 activation controls the nuclear localization of β-catenin (Wu
et al., 2008). However, the β-catenin/TCF target gene Axin-2 was
similarly expressed in both Rac1 mutants and controls at E11,
suggesting that Rac1 is not required for appropriate Wnt/β-catenin
signaling in NCCs (Suppl. Fig. 3).
Depletion of Rac1 in neural crest leads to severe cardiovascular defects
NCCs play a critical role in the development of pharyngeal arch
arteries (PAAs), and formation of the aortico-pulmonary (AP) septum
(Hutson and Kirby, 2003). In combination with other structures, this
enables appropriate division of the single vessel that leads from the
distal end of the outﬂow tract, the aortic sac, into separate aortic and
pulmonary trunks. When this fails to occur, the single vessel that
results is classiﬁed as common arterial trunk (CAT) or solitary arterial
Fig. 1. Craniofacial defects in Rac1/Wnt1-Cre mutant embryos. At E10, the Rac1/Wnt1-Cre conditional knockout embryo (B) appears superﬁcially unaffected when compared to
control (A); however, histological sections show epithelial detachment from the underlying mesenchyme in mutant mandibular arch (arrow in D). At E11 (E–F), mutant embryos
have large superﬁcial blisters on mandibular arches (arrows in F). The mutant (H) heads are generally broader than those of controls (G) with a wide separation between the medial
nasal processes (double-headed arrows; G, H; in situ hybridization for Axin-2). Epithelial detachment can also be seen in the midline region between the two nasal processes
(F; arrowhead) corresponding to the positionmarked by an asterisk in H. At E12, the Rac1/Wnt1-Cremutant embryo has a severemid-facial cleft (J; asterisk) and rudimentary maxillary
processes (L; asterisk). Arrow in J points to anepithelial blister in theﬁrst pharyngeal arch. At E13, amutant (N) shows facial and cranial hemorrhaging (arrow)when compared toa control
littermate (M). Histological sections at the level of nasal cavities (O, P) and at eye level (Q, R) show that at E13 the posteror palatal shelves (arrow heads) are much smaller in mutants
(R) than in controls (Q) and overall amount of the craniofacial mesenchyme (asterisks in O, P, Q and R) in mutants is reduced. Scale bars indicate 500 µm: F as E; P–R as O.
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(PTA).
Our histological examination showed that in all Rac1/Wnt1-Cre
mutant embryos development of the arterial tree downstream of the
heart became increasing abnormal, consistent with a cessation of nor-
mal remodelling as well as dysmorphogenesis (Fig. 3). H&E-stained
sections of controls at E11 showed septation of the aortic sacwaswell
advanced. PAAs 3, 4 and 6 appeared of similar diameter, PAAs 3 and 4
arising from common paired extensions of the distal aortic sac
(‘ventral aorta’) (Fig. 3A and data not shown). In mutants, the lumen
of the aortic sac/ventral aortas appeared enlarged, with only two of
the PAA (3 and 6) being continuous to the dorsal aorta (Fig. 3B and
data not shown). PAA4 were present but of very small diameter and
not always continuously lumenised (Fig. 3S). Pulmonary arteries
arose from PAA6 as normal.
By E12, when control embryos had formed separate arterial trunks
and a recognizable asymmetric aortic arch structure, the common
trunk in mutants connected to dramatically dilated bilateral blood-
ﬁlled vessels each with a solitary and abrupt connection to anappropriate-sided and more normal-sized dorsal aorta (Figs. 3C–D).
The detailed anatomy of the dorsal aortas (data not shown) suggests
the dilated vessels connected at a level equivalent to that of PAA3/
distal common carotid arteries. Distally, each enlarged vessel also
gave rise to a small ventral vessel in a position consistent with this
being PAA2. No evidence of separate PAA6/arterial duct or PAA4
vessels could be found by E12. The same abnormalities were found at
E13, but the bilateral arterial vessels were even more enlarged,
intruding into the ventral body wall of the neck, and pressing against
the dense mesenchyme and differentiating cartilage in the tracheal/
laryngeal region. The relative diameter of the dorsal aortas to which
they connected was even smaller (Figs. 3H, J).
The smoothmuscle walls of the great arteries are normally formed
by NCCs (Jiang et al., 2000; Nakamura, 1982), whereas those
surrounding the dorsal aortas are of mesodermal origin. Like the
great arteries of the controls, the aberrant vessels in mutants
were also surrounded by wall containing smooth muscle alpha-actin
(SMα-A)-positive cells (Figs. 3G–J). Adjacent to the trunk these walls
appeared very thick but this is partly due to the plane of sectioning.
Fig. 2. Early distribution of neural crest-derived craniofacial mesenchyme in Rac1/
Wnt1-Cre mutants. R26R fate determination assay of control (A) and mutant
(B) samples at E10. The neural crest (NC)-derived mesenchyme has been visualized
by β-galactosidase staining (blue cells in A and B).White arrows in A and B illustrate the
more medial NC boundaries in control (A) than mutant (B). Horizontal sections of
control (C, E) and Rac1/Wnt1-Cremutants (D, F) show an acellular subepithelial region
in the midline at E11 in mutants (black arrows in D and F). A lateral accumulation of
mesenchymal cells adjacent to the telencephalon can be seen in Rac1/Wnt1-Cre
mutants (red arrow in F), but not in controls (E). TE, telencephalon; nc, nasal cavity.
Scale bars indicate 500 µm: D as C; F as E.
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most of these enormous vessels at an (irregular) thickness of up to
ﬁve cell layers, the latter similar to that of control brachiocephalic and
common carotid arteries at E13 (Figs. 3G–J and data not shown). The
thickness of the dorsal aorta smooth muscle walls differed little
between controls and mutants.
Within the outﬂow tract (OFT) of the heart itself, abnormalities in
the outﬂow tract cushions of the mutant embryos were demonstrable
at E11. Proximally, the endocardially-derived OFT cushions inmutants
were of similar structure to those in controls (Figs. 3K, L). More
distally, the usual arrangement of two prominent OFT cushions
positioned opposite one another across a slit-like lumen was present
in controls, so that on their fusion two separate ﬂow routes would be
created connecting the outlets of the ventricles to their respective
arterial trunks (Fig. 3M). In contrast, the mutants lacked two distinct
cushions in this region, cushion tissue had a smaller volume, and was
inappropriately positioned on the ventral side of the OFT (Fig. 3N),
creating a single off-center ﬂow route. By E12, this single route,
connecting to both ventricular apices, was positioned above the right
ventricle and led to a single trileaﬂet valve and thence a single arterial
trunk from the posterior/dorsal side of which the pulmonary arteries
arose directly (Figs. 3D, F).
Septation of the aortic sac into aortic and pulmonary trunks (AP
septation) was well advanced or complete in the control samples at
E11, and although the mutant sample contained an AP-septum-like
structure (Fig. 3P) reminiscent of control E10 embryos (Fig. 8A), it was
too anteriorly positioned and AP septation failed in mutants. This
structure contained NCC continuous with other pharyngeal mesen-
chymal cells (Figs. 5F, H), but simply divided the ‘ventral aorta’ into
left and right compartments (Fig. 3R), not PAA3 and 4 from PAA6.
Control and mutant embryos also differed prominently in that
tissue sections of this region in mutant embryos at E11 consistently
showed irregular shaped regions of low mesenchymal cell density
adjacent to the aortic sac/ventral aorta vessel walls and ventralpharyngeal endoderm (Figs. 3R, S). Such spaces were not found in
control embryos (Figs. 3A, Q) and could be distinguished from vessels
by their irregular shape and the lack of SMα-A-positive cells around
them (Fig. 3S).
To further characterize the differences in aortic sac and PAA
structure between controls and mutants, intra-cardiac Indian ink
injections were performed at E10 and E11. At E10 development of
lumenised PAA4 and 6 was delayed in mutants and PAA3 enlarged.
Consistent with our histological ﬁndings, arch vessels were of similar
diameter to one another in controls at E11 (Fig. 4B) but, although
PAA3 and PAA6 were present and patent, the lumen of PAA4 was only
of very small diameter in mutants by E11 (Fig. 4D). Whole-mount
PECAM-1 immunostaining (Figs. 4E–H), which reveals the extent of
endothelial vessel formation even if not fully lumenised, showed the
continued predominance of PAA3 at E10.5 in mutants and an already
enlarged aortic sac relative to control which remained more aligned
with PAA3 than PAA4 in mutant embryos (Figs. 4E, G).
In summary, mutant embryos formed abnormal OFT cushions and
exhibited delayed PAA development. The OFT and enlarged aortic sac
failed to septate and adjacent pharyngeal mesenchyme developed
irregular hypocellular cavities. Instead of the aortic arch and arterial
duct arteries, the resulting abnormal single arterial trunk connected to
bilateral aneurysmal arterial vessels with incomplete smooth muscle
walls that dilated very rapidly between E11 and E12 and continued to
dilate if the embryo survived to E13. These vessels each made a single
connection to a more normal-sized left or right-sided dorsal aorta at
the level of the distal common carotid arteries.
Neural crest cells lacking Rac1 migrate normally in vivo but show defective
spreading in vitro
To identify abnormalities in migration of NCCs in vivo, we used the
R26R fate determination assay (Soriano, 1999). Control and mutant
whole-mount staining patterns were carefully compared at E9.0 and
E10.0. In accordance with the previously published study (Fuchs et al.,
2009), we could not detect any evidence of gross differences in NCC
migration between these mutant and control samples (Figs. 5A–D).
RNA ISH for Cadherin-6, also a marker for migrating NCCs, did not
demonstrate any signiﬁcant overall differences in staining pattern
either (Suppl. Fig. 4). Concordant with this, we could not detect
consistent differences between the most proximal (‘upstream’)
position in the OFT to which NCC had migrated in controls and
mutants at E11 (Figs. 5E–H) suggesting that even though NCCs do not
enter the distal OFT before E9.5, the OFT septation defect in mutants
was not due simply to a failure of any NCCmigration deep enough into
the heart. Rac1 has a well-documented role in cellular migration in
vitro (Fukata et al., 2003; Pankov et al., 2005) so wewere interested to
test the migratory potential of NCCs from neural tubes in 2D culture
but since Rac1-deﬁcient NCCs failed to migrate from neural tube
explants in sufﬁcient numbers we were unable to obtain Rac1-
deﬁcient NCCs for further study by this route (Supple. Fig. 5A, B).
Since Rac1 has been shown to play an important role in
reorganization of the actin cytoskeleton, we tested whether NC-
derived cells lacking Rac1would spread normally on 2D matrices. We
dissected 1st pharyngeal arches from E10 embryos, dissociated them
into a single cell suspension and plated the cells onto ﬁbronectin-
coated plates. The cultures were harvested after 48 h and stained for
β-galactosidase activity (Figs. 6A–B), which demonstrated that more
than 80% of cells in both mutant and control cultures were derived
from NC. While the control NCCs spread well and formed numerous
ﬂat membranous protrusions, the mutant NCCs spread poorly, and
had an elongated morphology (Figs. 6C–F). Along with impaired
spreading, the mutant cells showed poor attachment. About 80% of
control cells, but only about 20% of mutant cells had attached on
ﬁbronectin-coated plates after 5 h (data not shown). After 1–3 days in
culture, the control andmutant NCCswere stained for f-actin and focal
Fig. 3. Pharyngeal arterial and cardiac outﬂow tract defects in Rac1/Wnt1-Cremutants. A–J; At E11, Outﬂow tract (OFT) and aortico-pulmonary (AP) septation are in progress and an
OFT with well-developed cushions leads to discrete anterior/posteriorly arranged trunk precursors in control (A,) but in mutant (B) a much broader common vessel extends from
aortic sac to third pharyngeal arch artery (PAA3). At E12, discrete aortic (AoT) and pulmonary (PT) trunks indicate normal AP septation has occurred in control (C). Only PT connects
to pulmonary arteries (below the plane of sectioning) and to the top of the descending aorta (DA) via the arterial duct (AD). In mutant (D) a single three leaﬂet valve (red asterisk)
leads to a large, common arterial trunk (CAT) indicating failure of AP septation, and connects both to pulmonary arteries (Pa) and two dramatically dilated bilateral vessels (*) each of
which eventually makes a sole connection to a normal-sized dorsal aorta (left dorsal aorta, LDA; right dorsal aorta, RDA). At E13, the same structures and differences are present in
control (E, G, I) and mutant (F, H, J). Smooth muscle α-actin (SMα-A)-positive cells shown in red, nuclei in blue. The mature pattern of great arteries is present in control
(G) including right (RCC) and left common carotid (LCC) arteries. In mutant (F, H, J) the abnormal arterial vessels (*) leading from the common trunk are even more dilated, pressing
against dense medial mesenchyme around the trachea (Tr) and laryngeal (La) structures and partially interrupting the neck wall (F: arrowhead). They empty only into relatively tiny
dorsal aortas (H: LDA, RDA). A high proportion of the abnormal vessel walls contains SM-αA-positive cells, even though the surface area is hundreds of times greater than that of the
control arteries. K–P: At E11, the proximal parts of the two OFT cushions are distinct and similarly oriented in both control (K) andmutant (L) embryos. More distally the neural crest
(NC)-derived OFT cushions lacking Rac1 appear fused, smaller and abnormally positioned on the posterior side of the OFT (N) compared to corresponding control cushions
(M), creating a single off-center ﬂow route. While AP septation has occurred in the control sample (O; the AP-septum is not a separate structure any more), the mutant sample
displays a NC-derived AP-septum-like structure (P; arrow; see also Fig. 5H). Q–S: Mutant pharyngeal mesenchyme contains abnormal irregular cavities (arrowheads in R and S) that
are not visible in comparable area of control (Q, asterisk). Cells surrounding these cavities do not stain positive for SMα-A (S). 3, 4, 6: 3rd, 4th, 6th pharyngeal arch arteries
respectively; Ph, pharynx. Scale bars indicate either 500 µm (B as A; D as C; F–J as G; L–N as K); or 250 µm (P as O; R as Q; S).
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Once again, the NC origin was conﬁrmed, this time using immunostain-
ing for β-galactosidase. Control NCCs spread well, forming a large
number of focal adhesion complexes and a web-like actin ﬁlament
network. In contrast, the mutant NCCs displayed very few focal
adhesion complexes per cell and few actin ﬁlaments all arranged
parallel to the long axis of the cell (Figs. 6G–J). Very similar attachment
and spreading behaviors, and the samedifferences between control and
mutant genotype cells, were demonstrated whether the cells were
plated on ﬁbronectin-, laminin- or collagen-coated dishes. To furtherexamine regulation of cell spreading, control and mutant cells were
treated with growth factors. The preparatory serum starvation led to a
rapid rounding up of mutant cells while control cells were unaffected
(Figs. 6K, L). Subsequent stimulation with EGF and bFGF (100 ng/ml
each) induced a detectable increase in spreading (Fig. 6N) suggesting
that Rac1-deﬁcient cells are at least partially able to respond to growth
factor stimulation after serum starvation, although their morphology
was still abnormal (Figs. 6K–O).
To conclude, these results demonstrate Rac1/Wnt1-Cre NCCs
exhibit poor cell attachment and spreading in vitro. Defective cell–
Fig. 4. Abnormal patterning of pharyngeal arch arteries in Rac1/Wnt1-Cre mutants. Left lateral view after intra-cardiac ink injection of pharyngeal arch arteries (PAAs) in controls
(A, B) and mutants (C, D) at E10 (A, C) and E11 (B, D). All three PAAs; (3, 4, 6) are detectable in control samples (A, B), while in the mutant sample at E10 only a prominent 3rd PAA
can be seen. At E11, the mutant displays a prominent 3rd PAA and relatively normal-looking 6th PAA, while the narrow 4th PAA lumen is not completely patent (D). Whole-mount
immunostaining for CD31 (PECAM1) at E10.5 showed a wider, abnormally aligned aortic sac in mutant (G) when compared to control (E). Green lines illustrate a difference in
alignment between control (E) and mutant (G). Blue lines illustrate diameter of distal OFT. The vascular bed of the ﬁrst pharyngeal arch in the mutant (H) was similar to that of the
control (F) at E10.
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these behaviors and the abnormally low mesenchymal cell density in
craniofacial and pharyngeal regions observed in vivo.Neural crest cell proliferation, survival and differentiation in Rac1/Wnt1-
Cre mutants
Next, we investigated whether the mutant phenotypes observed
might be contributed to by deﬁcient cell proliferation or aberrant cell
death in vivo, by using BrdU labelling and phospho-histone 3
immunodetection, and TUNEL staining, respectively. In general, NCC
proliferation in mutant and control tissues did not differ at either E10
or E11, stages by which the ﬁrst observed craniofacial and cardiac
phenotypic abnormalities were clearly detectable (Figs. 7A–C, and
data not shown). However, consistent with the recent report (Fuchs et
al., 2009), we did detect less proliferation of post-migratory NC-
derived cells in mutant embryos at E13 (Figs. 7D–E).
A strikingly higher incidence of cell death was detectable in the
largely NC-derived pharyngeal mesenchymal cells surrounding the
aberrant aortic sac and arch vessels in Rac1/Wnt1-Cre mutants
relative to controls at E11 (Figs. 7H–K). Although the incidence was
less, we detected more than twice the percentage of apoptotic cells in
the hypocellular craniofacial midline region at E11 in mutants as in
controls (Figs. 7F, G; data not shown). However, we could not
consistently associate the large blisters in lateral aspects of the
mandibular arch with elevated levels of apoptosis (data not shown).
We also made a careful comparison of NCC shape in the OFT
cushions of control and mutant embryos at E11, and demonstrated
that NC-derived control cells more often appeared elongated (had
longer cellular processes) than Rac1-deﬁcient cells which were more
often rounder due to shorter or absent processes (Figs. 7L–M). Similar
rounded cells were not detected in other mesenchymal regions
known to be populated by NC-derived cells.In addition to the craniofacial mesenchyme, OFT and AP septation,
stability of PAAs, and SMC formation, cranial NCCs also contribute to
development of afferent neurons and glial cells of the cranial ganglia
(Barlow, 2002; Kalcheim and Le Douarin, 1986; LeDouarin, 1982). We
therefore examined the morphology of cranial ganglia in Rac1/Wnt1-
Cre embryos by whole-mount immunohistochemistry with anti-
neuroﬁlament antibody at E11. In all mutant samples, the trigeminal
ganglia were reduced in size, the superior cervical ganglia (III)
disorganized, and the oculomotor nerves missing. The glossophar-
yngeal nerve (IX) branched from vagal nerve (X) in an aberrant
combined structure. The expression pattern of Sox10 in Rac1/Wnt1-
Cre mutants conﬁrmed their smaller trigeminal ganglia relative to
those in controls (Suppl. Fig. 6).
As cardiac cranial NCCs have important roles in OFT/AP septation
and smooth muscle wall formation, and mutant embryos had defects
in these structures and processes, we examinedmuscle differentiation
in this region more closely. NCCs are thought to regulate septation in
part by inﬂuencing the migration of adjacent secondary heart ﬁeld
cells into the distal OFT wall of the heart (Waldo et al., 2005a; Yelbuz
et al., 2002). Normally, a myocardial sleeve is formed as far as the
reﬂection of the pericardium/body wall at the distal end of the OFT at
E10 and such a pattern was indeed detected in sections of control
hearts using MF20 antibody staining (Fig. 8A). In mutant structures,
the most distal part of the sleeve was not MF20-positive, and a
disconnected population of MF20-positive cells was present between
the endothelium and outﬂow tract wall adjacent to the aortic sac
(Fig. 8B) suggesting that Rac1-deﬁcient NCCs were unable to perform
their normal role. A day later, secondary heart ﬁeld cells and cranial
NC start to differentiate into smooth muscle cells of the OFT valves,
trunks and great arteries downstream of the heart in a distinctive
pattern (Brown and Baldwin, 2006). To examine the initiation and
distribution of differentiating smooth muscle cells in this region,
SMα-A antibody staining was performed on sections at E11. There
were no striking differences in overall intensity or pattern of staining
Fig. 5. Neural crest cells deﬁcient in Rac1 migrate normally in vivo. Lineage tracing of migrating neural crest cells (NCCs) using whole-mount R26R fate determination assay at
E9 (A, B), E10 (C, D) and E11 (E–H). A–D: External lateral views of control (A, C) and mutant embryos (B, D) show identical staining patterns, including at the level of pharyngeal
arches 4–6 (arrowheads); E–F: whole-mount embryos dissected transversely at the outﬂow tract (OFT) level, and sections, demonstrating cardiac NCC migration into the OFT has
occurred to the same morphological position in control (E, G) and mutant (F, H) embryos (black arrows point to most proximally migrated positively staining (blue) NC-derived
cells; blue arrow points to an aortico-pulmonary septum-like structure containing blue NCCs; black arrowheads point to aberrant mesenchymal cavities). Hatched lines depict the
length of the OFT (E, F). Scale bar indicates 100 µm (H as G).
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cells but the SMα-A-positive cells forming the smooth muscle cell
layers in mutants appeared less tightly packed, and present in more
(disorganized) layers, thus failing to form as compact a layer around
the endothelial lining of the aortic sac region as seen in controls
(Figs. 8C–D). Expression of SMα-A per se is only a crude measure of
smooth muscle cell differentiation and it has been shown by others
(Wang et al., 2004) that the degree of normal ‘contractile’ smooth
muscle differentiation is controlled by a balance between myocd
(myocardin, a smooth muscle-speciﬁc transcriptional co-activator of
serum response factor) and activated Elk1 (a member of the Ets
family of transcription factors). Consistent with relatively strong
SMα-A staining levels in mutant SMCs, we could not detect any
increase in the level of phosphorylation of Elk1 in Rac1/Wnt1-Cre
mutants when compared to controls (data not shown) suggesting
that a lack of Rac1 does not affect themolecular switch regulating this
aspect of differentiation and would not contribute to the abnormal
organization.
We also examined a different aspect of differentiation, the
organization of smooth muscle cell contractile apparatus, by trans-
mission electron microscopy. Semi-organized ﬁlamentous actin
bundles (‘hairy actin’) were identiﬁed in about 50% of the smooth
muscle cells adjacent to distal aortic sac-derived vessels examined in
controls at E11 (n=10) (Fig. 8E) but despite intensive screening
similar subcellular structures could not be found around mutant
vessels (Fig. 8F) where cells appeared to be simply of a ‘secretory’
ﬁbroblast phenotype, even though they were clearly located in the
region where most cells were SMα-A-positive. Organized actinstructures were present in cells immediately adjacent to the
endothelial cells of dorsal aortas in both mutant and control samples
(data not shown), consistent with the smooth muscle cells here not
being of NC origin so not genotypically altered in mutant embryos.
Thus mutant cardiac NC-derived cells around the arterial structures
immediately distal to the heart differ in at least two respects from
their control counterparts. Overall, post-migratory Rac1-deﬁcient
NCCs in this region in mutants exhibited areas of defective cell
proliferation, cell survival, organization and differentiation.
In summary, these analyses imply that Rac1 is required in cranial
NCCs for appropriate differentiation and morphogenesis of post-
migratory NCCs and adjacent cells including frontonasal and pharyn-
geal arch mesenchyme, secondary heart ﬁeld cells, smooth muscle
cells, OFT cushion mesenchymal cells and cranial nerves. In vitro,
Rac1-deﬁcient NCCs were defective in cell–matrix interactions, cell
attachment and spreading. Related defective mechanisms might also
underlie the examples of regionalized abnormally low mesenchymal
cell density, abnormal cell shape or higher incidence of cell death
coincident with or precedent to the abnormalities in the develop-
mental events in vivo listed above in Rac1/Wnt1-Cre mutants.
Discussion
In this study, we have analyzed the role of Rac1 in neural crest cells
(NCCs) during mouse embryogenesis by deleting Rac1 gene expres-
sion in NCCs with Wnt1-Cre. Our results show that Rac1 in NCCs is
required for normal craniofacial and cardiovascular development.
Mutant (Rac1/Wnt1-Cre) embryos consistently died during the
Fig. 6. Wnt1-Cre-induced recombination of Rac1 impairs neural crest cell spreading on 2D matrices. Rac1-deﬁcient neural crest (NC)-derived pharyngeal arch mesenchymal cell
cultures (B, D, F, H, J) showed reduced spreading, aberrant clumping (B), elongated phenotype and reduced number of focal adhesion complexes on ﬁbronectin when compared to
corresponding control cultures (A, C, E, G, I). A, B, R26R fate determination assay, arrows point to positively stained NC-derived cells; C–D, phalloidin staining, arrows point to actin
stress ﬁbers; G, H, immunostaining for Fak, white arrowheads point to positively staining focal adhesion complexes; E, F, I, J, immunostaining for β-galactosidase. After serum
starvation, most of the Rac1-deﬁcient cells showed a rounded phenotype (L; arrows point to rounded cells) when compared to corresponding control cells (K; arrows point to well-
spread cells). Growth factor stimulation with epidermal growth factor (EGF; 100 ng/ml) and basic FGF (bFGF; 100 ng/ml) inducedmoderate cell spreading inmutants (arrows in N),
although still remains less than in that in corresponding controls (M; arrows point to spread cells). Bar chart (O) shows quantiﬁcation of changes in cell spreading after stimulation
with EGF and bFGF (100 ng/ml each). Based on the diameter of an unspread cell (x), cells were divided into three groups: no spreading (blue column), modest spreading: Nx to 2x
(red column); extensive spreading: N2x (green column) and the percentage of cells in each group calculated. More than 200 cells were scored in each group. Scale bars indicate
either 100 µm (A, B; G as I; J as H; L, M, N as K) or 25 µm (C as E; D as F).
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outﬂow tract and great arteries and extensive areas of epithelial
attachment in the craniofacial and pharyngeal region. In this report
we present evidence that Rac1-dependent patterning, cell spreading,
survival, proliferation and differentiation contribute to these pheno-
typic features.
A recent paper from Fuchs et al. reports an analysis of mice of a
very similar mutant genotype (Fuchs et al., 2009). The phenotypic
features described in our present study are summarized and
compared with those of Fuchs et al. (2009) in Table 1, and areconsidered in greater detail elsewhere in this Discussion. The broad
phenotypes of Rac1/Wnt1-Cre mutants described by Fuchs et al.
(2009) are consistent with their hypothesis that loss of Rac1 leads to a
depletion of the neural crest pool due to its failure to proliferate in
response to EGF. While our ﬁndings are in full agreement with the
statement that post-migratory NC-derived cells deﬁcient in Rac1 fail
to proliferate normally, some of the defects, particularly the epithelial
detachment and associated mesenchymal cavity formation, occur
earlier than the ﬁrst detectable abnormalities in cell proliferation.
This, together with the fact that other NC-speciﬁc mutants which
Fig. 7. Effect ofRac1 inactivation inneural crest cells on cell proliferation, apoptosis and cellularmorphology in vivo. A–C,BrdU incorporation assay to assessmesenchymal cell proliferation
in theﬁrst and secondpharyngeal archesatE10.BrdU-labellednuclei green, counterstain red (A, control; B,mutant). Bar chart inC shows thequantiﬁcation as apercentageofBrdU-positive
cells; blue column, control; red column, Rac1/Wnt1-Cremutant; error bars depict standard deviation (n=3). D–E: Cell proliferation is dramatically reduced in Rac1-deﬁcient neural crest
(NC)-derived palatal mesenchyme at E13 (E) relative to control (D) (BrdU incorporation assay: BrdU-labelled nuclei red, (white arrowheads), counterstain DAPI blue; D, control;
E, mutant). Yellow arrowheads in B and E point to sites of epithelial detachment, hatched lines in D and E deﬁne the lateral boarder of the palatal shelf mesenchyme. F–G: TUNEL staining
(green; counterstain DAPI blue) of themidline frontal craniofacial region showing signal in the highly hypocellular NC-derivedmesenchyme of a Rac1/Wnt1-Cremutant sample (G,white
arrowhead) compared to a corresponding control specimen (F). H–K: TUNEL staining (green; counterstain DAPI blue) in the largely NC-derivedmesenchyme surrounding distal outﬂow
tract (OFT) and abnormal downstream vessels (white arrowheads in I, K) and also in the AP-septum-like structure (yellow arrow in I) showsmore apoptosis in Rac1/Wnt1-Cremutants
when compared to equivalent regions in controls (white arrowheads in H and J). L–N: NC-derived OFT cushionmesenchymal cells (blue: R26R fate determination assay; black arrows) in
Rac1/Wnt1-Cre mutants (M) appear more often rounder, with shorter cellular projections, than the corresponding control cells (L). Black arrows (L) point to elongated cells; black
arrowheads (L,M) point to round cells. Bar chart (N) shows quantiﬁcation of the cell shape differences: Percentage of cells with a length:width ratio≥2 shown for controls (blue column)
andmutants (red column); error bars show standard deviation (n=3); *pb0.05 (Wilcoxon rank sum test). Scale bars indicate 250 µm inD andH–L, and 500 μm in F (E as D; I as J; G as F).
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Fig. 8. Abnormal outﬂow tract and vessel wall differentiation in Rac1/Wnt1-Cre
mutants. Immunostaining for MF20 in distal outﬂow tract (OFT) of control E10 heart
(A) shows a continuous sleeve of expression to the body wall reﬂection (white
arrowhead) but in mutant (B) MF20-expressing cells are aberrantly located (white
arrows). Low power images shown in insets (A, B). At E11, neural crest cells (NCCs)
deﬁcient in Rac1 (D) immunostained for smooth muscle α-actin (SMα-A) form a more
extensive and irregular layer (arrow heads) around the proximal arterial vessels than
those in controls (C). E, F: Transmission electron micrographs of putative smooth
muscle cells adjacent to endothelial cells in a position slightly distal to one such as in C,
D. Distinctive semi-organized f-actin bundles shown in inset E (black arrowhead) could
be found in many control cells but none of the mutant cells (F) examined. AS, aortic sac;
CAT, common arterial trunk; SMC, smooth muscle cell; SMC-L, SMC-like cell in mutant;
EC, endothelial cell. Scale bars indicate either 250 µm (B as A), 200 µm (D as C) or
500 µm (E and inset, F).
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defects in epithelial attachment or mesenchymal condensation (Chen
et al., 2007; Ko et al., 2007), suggests that factors other than reduced
size of the NC pool contribute to some of the phenotypes we report
here. As the genetic approach used by Fuchs et al. and us are so similar,
what might cause the striking differences in the resulting pheno-
types? Both studies used the same very well validated Wnt1-Cre
driver line, but the design of the responder line (ﬂoxed Rac1) is aTable 1
Phenotypic comparison of Rac1/Wnt1-Cremutant embryos between the present study
and that of Fuchs et al. (2009).
Phenotype Present study Fuchs et al. 2009
Lethality By E12.0 From E13.5
NCC migration in vivo Grossly normal Grossly normal
Cleft face Yes Yes
Epithelial detachment Yes, detectable at E10.0 Not reported
Mesenchymal acellular cavities Yes, detectable at E11.0 Not reported
Reduced proliferation of
post-migratory NCCs
Yes, detectable at E11.5 Yes, detectable at
E11.5
AP septation defect Yes Yes
Abnormal arch artery development Yes Not reported
Elevated apoptosis in post-migratory
NCCs
Some regions by E11.0 Not detected
NCC migration from neural tube
explant, (2D, in vitro)
Defective Normal
Post-migratory NCC spreading
(on 2D matrix in vitro)
Defectivea No abnormalities
reported
AP aortico-pulmonary; NCC neural crest cell.
a Post-migratory NCCs derived from the ﬁrst pharyngeal arch.possible candidate: in our mutants exon1 of the Rac1 gene was ﬂoxed
(ﬂanked by loxP sites), while exon 3 was ﬂoxed in those studied by
Fuchs et al. This subtle difference might lead to minor disparities in
efﬁciency and or timing of early recombination which, in turn, could
lead to a much more substantial divergence in early phenotypes.
Rac1 deﬁciency, cell morphology and neural crest cell migration
Rac1 has been shown to play an instrumental role in epithelial and
mesenchymal cell polarization, and in cell migration in vitro and in
vivo (Schmitz et al., 2000). In particular, Rac activation at the leading
edge has been shown to be a key event for directional migration
(Grande-Garcia et al., 2005; Nishiya et al., 2005), and a precise level of
Rac1 signaling is required for persistent directional migration, which
is then maintained by numerous feedback loops (De Calisto et al.,
2005; Ridley et al., 2003; Wallingford, 2005). Therefore, the degree of
apparently normal migration of Rac1-deﬁcient NCCs in vivo, as shown
previously (Fuchs et al., 2009) and conﬁrmed by the present study, is
quite remarkable. How can these in vitro results and our in vivo results
be reconciled? One major difference is that cells migrating in vivowill
often be responding to three-dimensional cues and conditions,
whether with matrix or other cells. Matrix composition in vivo is
complex and dynamic and has yet to be fully described. There is
currently no satisfactory three-dimensional in vitro culture system in
which to study onset and early NCC migration so this aspect must
remain unresolved.
Despite apparently normal NCC migration in vivo, and consistent
with the expected phenotype, Rac1-deﬁcient NC-derived cell cultures
showed poor plating efﬁciency, aberrant clumping, reduced spreading
and long narrow cell shape associatedwith fewer, parallel stress ﬁbers
and a reduced number of focal adhesion complexes. This phenotype is
very similar to that of Rac1-deﬁcient embryonic ﬁbroblasts (Guo et al.,
2006) and of non-migratory cells with very low Rac1 activity (Pankov
et al., 2005), and is consistent with the observed in vivomesenchymal
phenotypes of abnormally low cell density often associated with
detached epithelium (in several locations), and abnormal cell
morphology (in OFT cushions).
Epithelial blisters, mesenchymal cavities, and mid-facial clefting
Deletion of Rac1 in the NC leads to embryonic lethality duringmid-
gestation with defects in craniofacial structures, cardiac outﬂow tract
and pharyngeal vessels. A consistent early and novel phenotype of
Rac1 mutant embryos is acellular or hypocellular regions between
epithelia and mesenchymal cells (blistering) or within mesenchyme
(irregular cavities), which was detectable as early as E10. It should be
noted that reduced proliferation was observed in post-migratory
NCCs only much later (≥E11.5) and thus it is unlikely that the
observed phenotypes would be caused by inability of NC-derived cells
to respond to mitogenic stimuli.
Blistering was always ﬁrst detected on the lateral aspects of the
mandibular arch, but occurred later at other sites in which the
underlying mesenchyme is populated by NC-derived cells. These
included the maxillary processes, craniofacial midline and posterior
pharyngeal mesenchyme. The blisters and hypocellular regions in the
craniofacial mesenchyme and posterior pharyngeal mesenchyme
were associated with increased cell death. However, an occurrence
of apoptotic cells was not strictly limited to the immediate vicinity of
hypocellular or blister regions; Instead, they were relatively broadly
spread through the NC-derived mesenchyme in these areas. Based on
these ﬁndings, and in conjunction with a previous published report
demonstrating that in an unrelated NC-speciﬁc mutant a dramatic
increase in the level of apoptosis in post-migratory NCCs did not lead
to a similar formation of hypocellular regions (Wang et al., 2006), we
conclude that, while increased apoptosis is likely to be an important
contributory factor to the observed phenotypes, other mechanisms
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their initiation, and subsequently.
Despite the enormous size and degree of epithelial detachment in
the blisters there, the lower jaw developed relatively normally. In
contrast, the upper jaw became severely malformed as mutant
embryos developed a mid-facial cleft by E12. A direct role for lateral
blistering in this seems unlikely. Instead, the epithelial blistering and
adjacent hypocellular mesenchyme we observed in the facial midline
at E11 is strongly implicated as a key marker of embryos in which
mid-facial fusion will fail and perhaps part of the underlying
mechanism. The same feature was considered instrumental previ-
ously in the mid-facial clefting in mice exposed to the teratogenic
amino acid analogue diazo-oxo-norleucine (DON) at E11 (Burk and
Sadler, 1983). DON-treated embryos also display wide separation of
medial nasal processes and abnormal widening of the anterior face
and head, closely resembling those seen in Rac1/Wnt1-Cre embryos,
along with larger lateral accumulations of NCC. This implies that the
mid-face clefts seen in Rac1 mutants result from an abnormal
distribution of post-migratory NC-derived craniofacial mesenchyme
during facial development, one result of which is mesenchymal
hypocellularity and epithelial blistering in the midline.
Cardiac outﬂow tract and pharyngeal defects in Rac1/Wnt1-Cre mutants
Rac1/Wnt1-Cremutants display aberrant patterning of pharyngeal
arch arteries, followed by common arterial trunk (‘persistent truncus
arteriosus’) and highly aneurysmal bilateral distal pharyngeal arteries.
It was recently suggested that an adequate number of NCCs is
required for the normal architecture of the aortic sac, and stabilization
of nascent posterior PAAs 4 and 6, which in turn is required for
appropriate AP septation (Bradshaw et al., 2009). Thus, it is possible
that despite seemingly normal NCCmigration, the observed defects in
great artery development result from a reduced number and/or other
aspect of behaviour of NCC adjacent to developing PAAs 4 and 6. Rac1-
deﬁcient NC-derived pharyngeal mesenchyme also develops aberrant
cavities, around the aortic sac and ventral aorta, clearly detectable at
E11. These cavities lie immediately adjacent to, and precede the most
acute dilation phase of, the abnormal arterial vessels, making it likely
that an inadequate quantity of extra-arterial mesenchyme contributes
to the formation of the aneurysmal vessel phenotype present by E12.
Details of later anatomy suggest that the aberrant great arterial
vessels in mutants are derived largely from ventral aorta, again
consistent with the location of hypocellular mesenchyme at E11.
Although a number of models with abnormal neural crest
genotypes display OFT and AP septation failure and a common arterial
trunk, the development of extremely dilated arterial vessels down-
stream of this distinguishes our model from many other NC-speciﬁc
mutant phenotypes. However, a severely dilated arterial trunk
phenotype is present in NC-speciﬁc Pinch1 mutants (Liang et al.,
2007) very similar to that seen in our Rac1-deﬁcientmodel. Pinch1 is a
LIM domain containing adapter protein that has been shown to
mediate integrin/integrin-linked kinase-dependent signaling (Clark
et al., 2003; Hobert et al., 1999). Previous studies have implicated Rac1
in integrin-mediated cell matrix interactions and suggested that loss
of Rac1 leads to anoikis (Guo et al., 2006), whichmay contribute to the
hypo- and acellular mesenchymal phenotype seen in this study
especially the aortic sac-adjacent pharyngeal mesenchyme in which
more apoptosis was most clearly detectable. Since numerous studies
have implicated Rac1 in integrin signaling (Nishiya et al., 2005; Ridley
et al., 2003; Rose et al., 2007), it is tempting to speculate that in
cardiac NCCs both Rac1 and Pinch1 interact with the same integrin
signaling pathway to regulate critical cell–matrix interactions.
Integrins are major receptors for ECM molecules but are molecularly
highly varied (Giancotti and Ruoslahti, 1999). Little is known about
precisely which ones regulate these aspects of development in NCCs
other than that β1 integrins, which represent the largest subfamily ofβ integrins, are not essential for migration or septation (Breau et al.,
2009). In contrast, a recent report showed that focal adhesion kinase
(Fak), which is activated by integrin signaling, plays a critical role in
OFT septation (Vallejo-Illarramendi et al., 2009). While the overall
cardiac phenotype of Fak/Wnt1-Cre mutants appeared milder than
that of corresponding Rac1 mutants, the Fak-deﬁcient OFT cushion
mesenchymal cells displayed an aberrant rounded morphology,
which appeared very similar to that seen in our Rac1/Wnt1-Cre
mutants. A relationship between Fak and Rac1 is further supported by
our ﬁndings that immunostaining of cultured NC-derived pharyngeal
arch cells showed a markedly reduced pattern of Fak in focal adhesion
complexes although the total amount of Fak1 proteinmeasured in cell
lysates was not affected (data not shown). This is consistent with the
work by Guo et al. (2006) showing that Rac1 deletion greatly reduced
the number and size of focal adhesion complexes in mouse embryonic
ﬁbroblasts (MEFs) but not the expression of focal adhesion complex
components. Another similarity between Rac1-deﬁcient NC-derived
cells and MEFs is their inability to respond to EGF stimulation (Fuchs
et al., 2009; Guo et al., 2006), while stimulation of NC-derived cells
with bFGF led to enhanced spreading (present study) or increased
proliferation (Fuchs et al., 2009).
The rounded cell shape of most of the NCC cells that populate the
OFT cushions may contribute to the abnormal morphology (shape,
reduced volume) of these cushions in mutants. A higher incidence of
apoptosis in OFT mesenchyme in mutants was not detected.
As well as defects in arch artery formation and stability, failure of
OFT and aortico-pulmonary septation, other mouse models also have
a somewhat shortened, very straight, rather symmetrical outﬂow
tract, and aberrantly located striatedmyosin-expressing cells adjacent
to an enlarged aortic sac (Bradshaw et al., 2009) that we observe in
Rac1mutants. In particular, these features are consistent with those of
Splotch2H/2H, attributed to the failure of NCC to regulate the location
and differentiation of secondary heart ﬁeld (SHF) cells at the distal
end of the OFT appropriately (Bradshaw et al., 2009). SHF cells
contribute not only to myocardium but also smooth muscle of the
arterial trunks (Waldo et al., 2005b) so the abnormal smooth muscle-
α-actin-positive cell wall around the aortic sac and ventral aorta in
Rac1/Wnt1-Cre mutants could also be a consequence of this.
Other mousemodels with common arterial trunk (CAT) frequently
survive to birth, but rarely have such dysmorphic arteries. Whatever
the functionality of the smoothmuscle wall of these abnormal vessels,
given their shape and large volume they are unlikely to behave as
normal arteries hemodynamically, compromising the supply of
oxygen and nutrients to all other tissues even in those embryos that
survive such a sudden expansion of arterial volume as occurs between
E11 and E12. Indeed, the occasional survivors to E12 may represent
those where the expansion was less severe. Embryos lacking Pinch1 in
NCCs have a similar great artery phenotype but survive to birth (Liang
et al., 2007), consistent with Rac1 not being simply a downstream
mediator of Pinch1-dependent functions.
In conclusion, our results demonstrate that Rac1 plays a critical role
in early post-migratory NCCs. Failure of Rac1 signaling leads to the
localized formation of aberrant epithelial blisters and mesenchymal
cavities in craniofacial and pharyngeal tissues which are sometimes
accompanied by apoptosis, thereby disrupting major morphological
events including facial midline fusion, OFT and AP septation and great
artery remodelling. Given the complexity of Rac1-mediated signaling,
future studies will be needed to clarify the roles of various Rac1-
regulated pathways in cardiac and craniofacial development.
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